BIOSURFACES

Basic Information

200 Homer Avenue, Unit 1P
ASHLAND, MA, 01721-1717

Company Profile

n/a

Additional Details

Field Value
DUNS: 131658739
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: n/a


  1. A Bioactive Nanofibrous Sewing Cuff for Treatment of Cardiac Valvular Disease

    Amount: $150,000.00

    PROJECT SUMMARY Cardiac valve repair or replacement is indicated when progression of degenerative disease or bacterial infection of the native valve results in valvular dysfunction, thereby impacting ...

    SBIR Phase I 2014 Department of Health and Human Services
  2. A Nanofibrous Bioactive Hemodialysis Access Graft

    Amount: $988,074.00

    DESCRIPTION (provided by applicant): Current gold standards for hemodialysis access to treat End-Stage Renal Disease (ESRD), radial cephalic vein fistulas and autogenous saphenous veins, have signific ...

    SBIR Phase II 2012 Department of Health and Human Services
  3. A Bioactive Prosthetic Vascular Graft

    Amount: $748,950.00

    DESCRIPTION (provided by applicant): Over 60,000 prosthetic grafts, which are primarily comprised of polyethylene terephthalate (polyester) or expanded polytetrafluoroethylene (ePTFE), are implanted i ...

    STTR Phase II 2011 Department of Health and Human Services
  4. A Nanofibrous Bioactive Hemodialysis Access Graft

    Amount: $111,079.00

    DESCRIPTION (provided by applicant): Current gold standards for hemodialysis access, radial cephalic vein fistulas and autogenous saphenous veins, have significant problems associated with their use. ...

    SBIR Phase I 2010 Department of Health and Human Services
  5. A Nanofibrous Bioactive Prosthetic Sewing Cuff

    Amount: $110,528.00

    DESCRIPTION (provided by applicant): Cardiac valve replacement using prosthetic valves is indicated when progression of degenerative disease or bacterial infection of the native valve results in valvu ...

    STTR Phase I 2009 Department of Health and Human Services
  6. A Bioactive Prosthetic Vascular Graft

    Amount: $100,000.00

    DESCRIPTION (provided by applicant): Over 60,000 prosthetic grafts, which are comprised of either polyethylene terephthalate (polyester) or expanded polytetrafluoroethylene (ePTFE), are implanted in ...

    STTR Phase I 2008 Department of Health and Human Services
  7. An Endothelial Progenitor Cell-Specific Nanofibrous Vascular Graft

    Amount: $499,998.00

    DESCRIPTION (provided by applicant): Over 60,000 prosthetic grafts, which are comprised of either polyethylene terephthalate (polyester) or expanded polytetrafluoroethylene (ePTFE), are implanted in ...

    SBIR Phase I 2008 Department of Health and Human Services
  8. STTR Phase I: Localized Gene Delivery from Implantable Arterial Devices

    Amount: $150,000.00

    This Small Business Technology Transfer (STTR) Phase I research project aims to develop a fibrous material for the embedment and gradual release of appropriate genetic material, including small interf ...

    STTR Phase I 2007 National Science Foundation
  9. Development of Infection-Resistant Suture Materials

    Amount: $744,617.00

    DESCRIPTION (provided by applicant): Infection remains as one of the major complications associated with utilizing biomaterials. Surgical site infections account for approximately 14-16% of the 2.4-mi ...

    STTR Phase II 2006 Department of Health and Human Services
  10. A Nanofibrous Biocomposite Small-Diameter Graft

    Amount: $750,000.00

    DESCRIPTION (provided by applicant): There is no small-diameter (< 5mm internal diameter) vascular prosthesis approved for clinical use in small vessel reconstruction. Current prostheses are not ca ...

    SBIR Phase II 2005 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government